ALK Positive
What’s got our Executive Director Ken Culver excited about the future of ALK+ lung cancer? Reporting from #ESMO26 in Mad

104 likes

What’s got our Executive Director Ken Culver excited about the future of ALK+ lung cancer?

Reporting from #ESMO26 in Madrid, Ken shares some of the research, conversations and collaborations giving our community reasons to be hopeful. From Dr Ben Solomon’s latest CROWN trial insights into how circulating tumor DNA (ctDNA) could help identify patients who may benefit from more intensive treatment, to exciting conversations with biotech and pharmaceutical companies working on the next generation of therapies. And beyond the science, a special highlight: bringing together 40 advocates from around the world to strengthen collaboration through our emerging Global ALK+ Alliance. The science is moving forward. Our global community is growing stronger. And together, we’re working to ensure that progress reaches everyone living with ALK+ cancer, wherever they live. #LungCancer #cancer #stage4 #research
See it on Instagram ↗